Back
ESC2025 Premium Access

Comparative assessment of CMR-determined extracellular volume metrics in predicting adverse outcomes

Session: Cardiac magnetic resonance insights into amyloidosis imaging
Topic: T1 and T2 Mapping
Speaker: Doctor K. Mascherbauer (Vienna, AT)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Katharina Mascherbauer

Medical University of Vienna, Vienna (Austria)
0 follower

7 more presentations in this session

Multimodality artificial intelligence-based major adverse cardiovascular events prediction in transthyretin amyloid cardiomyopathy patients

Speaker: Doctor G. Baj (Bern, CH)

Access
Abstract
Slides
Video
Like
Thumbnail

Prognostic impact of atrial fibrosis detected by cardiac magnetic resonance in patients affected by cardiac amyloidosis

Speaker: Doctor M. Dicorato (Bari, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

RGAN-Driven T1 Map Synthesis from OS-CMR: a step toward AI-assisted amyloidosis diagnosis

Speaker: Doctor F. Lotfikazemi (Montreal, CA)

Access
Abstract
Slides
Video
Like
Thumbnail

Brain amyloid accumulation in patients with transthyretin amyloid cardiomyopathy: a pilot study

Speaker: Doctor M. Ungericht (Innsbruck, AT)

Access
Abstract
Slides
Video
Like
Thumbnail

Feature tracking-cardiovascular magnetic resonance to predict major adverse cardiovascular events in patients with cardiac amyloidosis

Speaker: Doctor M. Dicorato (Bari, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Cardiac magnetic resonance insights into amyloidosis imaging

Speakers: Doctor K. Mascherbauer, Doctor G. Baj, Doctor M. Dicorato, Doctor F. Lotfikazemi, Doctor M. Ungericht...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources